Market Overview

UPDATE: Oppenheimer Upgrades UnitedHealth Group to Outperform; Valuation is Overly Pessimistic

Share:
Related UNH
CNBC's Stock Pops & Drops From February 23
Fast Money Halftime Report Final Trade From February 10
Cracking The Best Healthcare Dividend Stock Secrets (GuruFocus)

Oppenheimer upgraded UnitedHealth Group (NYSE: UNH) from Perform to Outperform and raises the price target from $63.00 to $66.00.

Oppenheimer commented, "We believe that UNH's current discounted multiples appear attractive in light of the overly-pessimistic outlook regarding the impact of the ACA, and the recent pull-back related to MA rates. Furthermore, following the Q4:12 earnings conference call, we have increased confidence that FY2013 results will outperform expectations. With strong cash flow, a well-diversified portfolio and a strong track record of performance, we would be buyers of UNH."

UnitedHealth Group closed at $55.21 on Wednesday.

Latest Ratings for UNH

DateFirmActionFromTo
Jan 2015Leerink SwannMaintainsOutperform
Jan 2015Deutsche BankMaintainsBuy
Jan 2015BarclaysMaintainsOverweight

View More Analyst Ratings for UNH
View the Latest Analyst Ratings

Posted-In: OppenheimerAnalyst Color Upgrades Analyst Ratings

 

Related Articles (UNH)

Around the Web, We're Loving...

Get Benzinga's Newsletters

Our Experts vs. S&P 500Powered by Benzinga
Marketfy Products Return S&P 500
Morning Profit Maker 42.72% 6.69%
The Option Prophet 91.14% 6.69%
SecretCaps 26.55% 6.69%
Short-Term Trend Trading 11.89% 6.69%
View the highest rated products→